Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 1037389 NEW YORK, NY
Back to SLS Full portfolio

Position in SLS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,580,972
+$4,111,139 QoQ
Shares Held
310,364
+6.4% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#28
of 192 holders
Holding Since
Jun 2020
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. SLS ranks #88 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in SLS

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,580,972 310,364
2025-09-30 $469,833 291,822
2025-03-31 $37,683 34,892
2024-09-30 $116,171 92,937
2024-06-30 $38,610 32,446
2023-12-31 $53,424 50,400
2022-09-30 $45,248 22,400
2022-06-30 $75,458 33,838
2020-06-30 $42,074 14,360